Abstract:Objective To investigate the diagnostic value and application of high-throughput sequencing (mNGS) in pulmonary infection pathogens.Methods A total of 258 patients with pulmonary infections (common gram-negative bacilli such as Staphylococcus aureus, Kleptobacillus pneumoniae, pseudomonas aeruginosa, Escherichia coli, acinetobacter baumannii, common viruses such as herpes simplex virus, Epstein-Barr virus, etc., common fungi such as candida albicans, Aspergillus, etc.) admitted to the Department of Respiratory and Critical Care Medicine of Xiaogan Central Hospital from January 2022 to December 2022 were selected. The patients' alveolar lavage fluid samples were collected for mNGS detection and routine sputum culture detection of pathogenic microorganisms, respectively, to evaluate the clinical application value of mNGS.Results Among the 258 patients included in the study, 200 patients were detected by mNGS, with a detection rate of 77.52%. There were 58 patients who underwent routine sputum culture detection, the detection rate was 22.48%. In conclusion, the total detection rate of pathogenic microorganisms detected by mNGS was significantly higher than that by conventional sputum culture detection, and the difference was statistically significant (P<0.05).Conclusion The detection rate of pathogenic microorganisms by mNGS in patients with pulmonary infection is significantly higher than that by conventional sputum culture detection, and the application value is higher. But relatively speaking, it has certain limitations. mNGS cannot determine whether the sequence it detects is from live or dead bacteria, nor can it distinguish between custom and pathogenic bacteria. In addition, the cost of mNGS is high, and it can be used as appropriate in clinic.